DPP-4 as a Possible Biomarker of Inflammation Before Abdominal Surgery for Chronic Pathology: Our Experience with Elective Cholecystectomy.
Conclusions: In the subacute or chronic phases of cholecystitis, there appears to be a constant consumption of DPP-4, which would modulate a better immune response that could be related to the reduction of postoperative complications, so the use of Serum levels of DPP-4 as an early biomarker could improve the diagnostic accuracy of this pathology and the surgical approach.
PMID: 31100960 [PubMed - in process]
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Valencia-Sánchez L, Almendra-Pegueros R, R-Valdez LJD, Esmer-Sánchez D, Medina Ú, Gordillo-Moscoso A Tags: Medicina (Kaunas) Source Type: research
More News: Autoimmune Disease | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholecystectomy | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | ERCP | Heart | Jaundice | Liver | Liver Disease | Medical Ethics | Obesity | Pancreatitis | Pathology | Peritonitis | Statistics | Study | Universities & Medical Training | Urology & Nephrology